Skip to main content
. 2016 Jul 18;49(1):219–229. doi: 10.4143/crt.2016.190

Table 1.

Summary of inhibitory effects (MTS50) of 83b1 on ESCC and non-tumor cell lines

MTS50 (μg/mL) for 72 hr
83b1 CDDP
ESCC cell line
 KYSE-150 11.72 8.58
 KYSE-450 9.71 15.85
 KYSE-520 12.47 10.08
 SLMT-1 5.87 8.99
 HKESC-2 5.94 1.98
 HKESC-4 6.87 18.81
Non-tumor cell line
 NE-1 5.15 1.03
 NE-3 > 50 0.02
 HEK001 133.30 1.94

ESCC, esophageal squamous cell carcinoma; CDDP, cisplatin.